DMPHF
Price:
$39.56
Market Cap:
$1.84B
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Al...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-11-29
Stock Exchange
OTC
Ticker
DMPHF
According to Dermapharm Holding SE’s latest financial reports and current stock price. The company's current Enterprise Value is 2.72B. This represents a change of -4.68% compared to the average of 2.86B of the last 4 quarters.
The mean historical Enterprise Value of Dermapharm Holding SE over the last ten years is 2.59B. The current 2.72B Enterprise Value has changed 10.44% with respect to the historical average. Over the past ten years (40 quarters), DMPHF's Enterprise Value was at its highest in in the December 2021 quarter at 5.22B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
2.59B
Median
2.48B
Minimum
1.37B
Maximum
5.23B
Discovering the peaks and valleys of Dermapharm Holding SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.96%
Maximum Annual Enterprise Value = 5.23B
Minimum Annual Increase = -54.35%
Minimum Annual Enterprise Value = 1.37B
Year | Enterprise Value | Change |
---|---|---|
2024 | 2.95B | -7.76% |
2023 | 3.20B | 34.13% |
2022 | 2.39B | -54.35% |
2021 | 5.23B | 47.14% |
2020 | 3.55B | 37.72% |
2019 | 2.58B | 87.96% |
2018 | 1.37B | -11.27% |
2017 | 1.55B | 6.14% |
2016 | 1.46B | -7.36% |
2015 | 1.57B | 0.19% |
The current Enterprise Value of Dermapharm Holding SE (DMPHF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.85B
5-year avg
3.46B
10-year avg
2.59B
Dermapharm Holding SE’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dermapharm Holding SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dermapharm Holding SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Dermapharm Holding SE's Enterprise Value?
What is the highest Enterprise Value for Dermapharm Holding SE (DMPHF)?
What is the 3-year average Enterprise Value for Dermapharm Holding SE (DMPHF)?
What is the 5-year average Enterprise Value for Dermapharm Holding SE (DMPHF)?
How does the current Enterprise Value for Dermapharm Holding SE (DMPHF) compare to its historical average?